- Home
- DRCT vs AEON Comparison
DRCT vs AEON Comparison
Compare DRCT & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- AEON
- Stock Information
- Founded
- DRCT 2018
- AEON N/A
- Country
- DRCT United States
- AEON United States
- Employees
- DRCT N/A
- AEON N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- AEON Health Care
- Exchange
- DRCT Nasdaq
- AEON Nasdaq
- Market Cap
- DRCT 9.2M
- AEON 8.0M
- IPO Year
- DRCT 2022
- AEON N/A
- Fundamental
- Price
- DRCT $0.46
- AEON $0.73
- Analyst Decision
- DRCT Strong Buy
- AEON Strong Buy
- Analyst Count
- DRCT 1
- AEON 1
- Target Price
- DRCT $6.00
- AEON $360.00
- AVG Volume (30 Days)
- DRCT 791.3K
- AEON 85.9K
- Earning Date
- DRCT 08-05-2025
- AEON 08-12-2025
- Dividend Yield
- DRCT N/A
- AEON N/A
- EPS Growth
- DRCT N/A
- AEON N/A
- EPS
- DRCT N/A
- AEON N/A
- Revenue
- DRCT $36,459,000.00
- AEON N/A
- Revenue This Year
- DRCT $16.81
- AEON N/A
- Revenue Next Year
- DRCT $62.96
- AEON N/A
- P/E Ratio
- DRCT N/A
- AEON N/A
- Revenue Growth
- DRCT N/A
- AEON N/A
- 52 Week Low
- DRCT $0.38
- AEON $0.38
- 52 Week High
- DRCT $6.59
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- DRCT 48.77
- AEON 48.08
- Support Level
- DRCT $0.44
- AEON $0.72
- Resistance Level
- DRCT $0.48
- AEON $0.80
- Average True Range (ATR)
- DRCT 0.04
- AEON 0.06
- MACD
- DRCT 0.01
- AEON 0.00
- Stochastic Oscillator
- DRCT 75.24
- AEON 59.94
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.